Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin
Authors:
- 1 December 2008
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (23) , 10049-10060
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin IIBioorganic & Medicinal Chemistry Letters, 2007
- In vitro antimalarial activity of hyperforin, a prenylated acylphloroglucinol. A structure–activity studyBioorganic & Medicinal Chemistry Letters, 2007
- Inhibitors of Plasmepsin II—potential antimalarial agentsBioorganic & Medicinal Chemistry Letters, 2006
- Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitorFEBS Letters, 2006
- Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systemsProceedings of the National Academy of Sciences, 2006
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparumFEBS Letters, 1994
- Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.Journal of Clinical Investigation, 1994
- KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.Chemical and Pharmaceutical Bulletin, 1991
- Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.Chemical and Pharmaceutical Bulletin, 1991